Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and design

Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and design

Abstract Bringing optimised coronavirus disease 2019 (COVID-19) vaccine schedules to immunocompromised populations (BOOST-IC) is a multi-site, adaptive platform trial designed to assess the effect of different booster vaccination schedules in the Australian immunocompromised population on the immuno...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Dymock, James H. McMahon, David Griffin, Michelle Hagenauer, Tom L. Snelling, Julie A. Marsh, On behalf of the BOOST-IC Investigator Team
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Trials
Subjects:
COVID-19
Vaccine
Immunocompromised
Adaptive trial
Statistical model
Bayesian
Online Access:https://doi.org/10.1186/s13063-025-08965-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13063-025-08965-w

Similar Items